American journal of obstetrics and gynecology
-
Am. J. Obstet. Gynecol. · Jul 1997
Multicenter Study Clinical TrialFetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial.
Our aim was to determine whether the presence of fetal fibronectin in vaginal secretions of patients with symptoms suggestive of preterm labor predicts preterm delivery. ⋯ In a population of patients with symptoms, the presence of fetal fibronectin in vaginal secretions best defines a subgroup at increased risk for delivery within 7 days; the high negative predictive value of fetal fibronectin sampling supports less intervention for patients with this result.